Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
Felipe Melo-González, Jorge A. Soto, Liliana A González, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke, Camila H. Coelho, Zeli Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 847-859.e11
Open Access | Times Cited: 781
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
Science Immunology (2022) Vol. 7, Iss. 69
Open Access | Times Cited: 407
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 21
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Esther Moga, Elionor Lynton-Pons, Peré Domingo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 42
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
Lirong Cao, Jingzhi Lou, See Yeung Chan, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1715-1722
Open Access | Times Cited: 39
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 28
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
Alison Tarke, Yun Zhang, Nils Methot, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101088-101088
Open Access | Times Cited: 25
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile
María Elvira Balcells, Nicole Le Corre, Josefina Durán, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e594-e602
Open Access | Times Cited: 34
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
Linda Petrone, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, et al.
International Journal of Infectious Diseases (2022) Vol. 121, pp. 24-30
Open Access | Times Cited: 30
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
Lu Lu, Lin‐Lei Chen, Ruiqi Zhang, et al.
EBioMedicine (2022) Vol. 79, pp. 103986-103986
Open Access | Times Cited: 30
Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021
Kun Xu, Chunxiang Fan, Yuxuan Han, et al.
International Immunology (2022) Vol. 34, Iss. 12, pp. 595-607
Open Access | Times Cited: 30
The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
Yao Jiang, Qian Wu, Peipei Song, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 29
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke, Camila H. Coelho, Zeli Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 39
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
Shiyao Xu, Jincheng Li, Hongyuan Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
Ricardo da Silva Antunes, Daniela Weiskopf, John Sidney, et al.
Current Protocols (2023) Vol. 3, Iss. 11
Open Access | Times Cited: 15
Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 32
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
Xiaoxu Han, Xiaobo Yu, Ying Han, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 2091-2100
Open Access | Times Cited: 22
Inducing broad-based immunity against viruses with pandemic potential
Alessandro Sette, Erica Ollmann Saphire
Immunity (2022) Vol. 55, Iss. 5, pp. 738-748
Open Access | Times Cited: 22
Current GMP standards for the production of vaccines and antibodies: An overview
Consuelo Covarrubias, Thomas Rivera, Catalina D. Alba Soto, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 21
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children
Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 20
Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
Pei Yu, Zijian Liu, Zhuoqi Zhu, et al.
Virologica Sinica (2023) Vol. 38, Iss. 2, pp. 233-243
Open Access | Times Cited: 12
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, et al.
EBioMedicine (2023) Vol. 91, pp. 104563-104563
Open Access | Times Cited: 12
T cells in SARS-CoV-2 infection and vaccination
Arthur P. Young
Therapeutic Advances in Vaccines and Immunotherapy (2022) Vol. 10
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top